Examining the impact of O-GlcNAcylation on RALY, we treated HCC cells with TMG, PUG and OE-OGT, and found that these stimulators could boost both overall O-GlcNAcylation and RALY protein levels at the same time. The gene discussed is OGT; the disease is hepatocellular carcinoma.